Your browser doesn't support javascript.
loading
DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features.
Mosella, Maritza S; Sabedot, Thais S; Silva, Tiago C; Malta, Tathiane M; Dezem, Felipe Segato; Asmaro, Karam P; Wells, Michael; Mukherjee, Abir; Poisson, Laila M; Snyder, James; deCarvalho, Ana C; Walbert, Tobias; Aho, Todd; Kalkanis, Steven; Elias, Paula C; Antonini, Sonir R; Rock, Jack; Noushmehr, Houtan; Castro, Margaret; Castro, Ana Valeria.
Afiliación
  • Mosella MS; Hermelin Brain Tumor Center, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Sabedot TS; Department of Genetics, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Sao Paulo, Brazil.
  • Silva TC; Hermelin Brain Tumor Center, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Malta TM; Department of Genetics, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Sao Paulo, Brazil.
  • Dezem FS; Hermelin Brain Tumor Center, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Asmaro KP; Department of Genetics, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Sao Paulo, Brazil.
  • Wells M; Department of Neurosurgery, Henry Ford Health System, Detroit, Michigan, USA.
  • Mukherjee A; Hermelin Brain Tumor Center, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Poisson LM; Department of Pathology, Henry Ford Health System, Detroit, Michigan, USA.
  • Snyder J; Hermelin Brain Tumor Center, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • deCarvalho AC; Center for Bioinformatics, Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA.
  • Walbert T; Hermelin Brain Tumor Center, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Aho T; Hermelin Brain Tumor Center, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Kalkanis S; Hermelin Brain Tumor Center, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Elias PC; Department of Radiology, Henry Ford Health System, Detroit, Michigan, USA.
  • Antonini SR; Department of Neurosurgery, Henry Ford Health System, Detroit, Michigan, USA.
  • Rock J; Internal Medicine Department, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Sao Paulo, Brazil.
  • Noushmehr H; Department of Pediatrics, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.
  • Castro M; Department of Neurosurgery, Henry Ford Health System, Detroit, Michigan, USA.
  • Castro AV; Hermelin Brain Tumor Center, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
Neuro Oncol ; 23(8): 1292-1303, 2021 08 02.
Article en En | MEDLINE | ID: mdl-33631002
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Tumores Neuroendocrinos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Tumores Neuroendocrinos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido